NPORT-EX 2 NPORT_IAL7_82843129_0222.htm FOR VALIDATION PURPOSES ONLY - [350270.IAL7]

PORTFOLIO OF INVESTMENTS – as of February 28, 2022 (Unaudited)

Loomis Sayles Global Growth Fund

 

    Shares    

    

Description

       Value (†)          
 

Common Stocks – 99.1% of Net Assets

 
  

Brazil – 7.2%

 

  977,627      Ambev S.A., ADR    $ 2,864,447  
  4,865      MercadoLibre, Inc.(a)      5,481,152  
     

 

 

 
        8,345,599  
     

 

 

 
  

China – 12.4%

 

  14,196      Alibaba Group Holding Ltd., Sponsored ADR(a)(b)      1,493,277  
  14,341      Baidu, Inc., Sponsored ADR(a)(b)      2,186,142  
  195,232      Budweiser Brewing Co. APAC Ltd., 144A      605,994  
  3,104      JD.com, Inc., Class A(a)      110,873  
  14,361      NXP Semiconductors NV      2,730,314  
  66,200      Tencent Holdings Ltd.(b)      3,572,239  
  65,206      Trip.com Group Ltd., ADR(a)(b)      1,683,619  
  36,551      Yum China Holdings, Inc.      1,901,383  
     

 

 

 
        14,283,841  
     

 

 

 
  

Denmark – 1.4%

 

  15,563      Novo Nordisk A/S, Class B      1,610,512  
     

 

 

 
  

France – 0.8%

 

  11,251      Sodexo S.A.      939,309  
     

 

 

 
  

Japan – 2.4%

 

  15,200      FANUC Corp.      2,792,272  
     

 

 

 
  

Netherlands – 3.9%

 

  2,154      Adyen NV, 144A(a)      4,489,523  
     

 

 

 
  

Switzerland – 12.3%

 

  33,997      CRISPR Therapeutics AG(a)      2,086,396  
  17,361      Nestle S.A., (Registered)      2,262,064  
  61,798      Novartis AG, (Registered)      5,431,512  
  11,666      Roche Holding AG      4,418,303  
     

 

 

 
        14,198,275  
     

 

 

 
  

United Kingdom – 4.3%

 

  72,686      Experian PLC      2,839,438  
  6,244      Reckitt Benckiser Group PLC      528,724  
  30,858      Unilever PLC      1,548,285  
     

 

 

 
        4,916,447  
     

 

 

 
  

United States – 54.4%

 

  19,925      Alnylam Pharmaceuticals, Inc.(a)      3,145,161  
  2,738      Alphabet, Inc., Class A(a)      7,395,721  
  2,557      Amazon.com, Inc.(a)      7,853,212  
  7,252      Autodesk, Inc.(a)      1,597,108  
  24,314      Boeing Co. (The)(a)      4,992,637  
  6,433      Colgate-Palmolive Co.      495,019  
  3,887      Core Laboratories NV      107,126  
  5,741      Deere & Co.      2,066,875  

        Shares         

    

Description

           Value (†)          
 

Common Stocks – continued

 
   United States – continued   
  9,350      Expeditors International of Washington, Inc.    $ 966,416  
  19,984      Meta Platforms, Inc., Class A(a)      4,217,223  
  17,706      Microsoft Corp.      5,290,376  
  5,710      Netflix, Inc.(a)      2,252,709  
  57,388      Oracle Corp.      4,359,766  
  16,199      QUALCOMM, Inc.      2,786,066  
  16,249      salesforce.com, Inc.(a)      3,420,902  
  15,959      Schlumberger NV      626,231  
  20,255      SEI Investments Co.      1,186,538  
  103,638      Under Armour, Inc., Class A(a)      1,854,084  
  9,134      Vertex Pharmaceuticals, Inc.(a)      2,101,003  
  24,399      Visa, Inc., Class A      5,273,112  
  7,259      Yum! Brands, Inc.      889,808  
     

 

 

 
        62,877,093  
     

 

 

 
   Total Common Stocks
(Identified Cost $100,899,448)
     114,452,871  
     

 

 

 
Principal
Amount
             
 

Short-Term Investments – 0.8%

 
$ 925,803      Tri-Party Repurchase Agreement with Fixed Income Clearing Corporation, dated 2/28/2022 at 0.000% to be repurchased at $925,803 on 3/01/2022 collateralized by $943,800 U.S. Treasury Note, 1.875% due 2/28/2027 valued at $944,390 including accrued interest(c)
(Identified Cost $925,803)
     925,803  
     

 

 

 
   Total Investments – 99.9%
(Identified Cost $101,825,251)
     115,378,674  
   Other assets less liabilities – 0.1%      98,555  
     

 

 

 
   Net Assets – 100.0%    $ 115,477,229  
     

 

 

 
(†)

Fund securities and other investments are valued at market value based on market quotations obtained or determined by independent pricing services recommended by the adviser and approved by the Board of Trustees. Fund securities and other investments for which market quotations are not readily available are valued at fair value as determined in good faith by the adviser pursuant to procedures approved by the Board of Trustees, as described below. Market value is determined as follows:

 

    

Listed equity securities (including shares of closed-end investment companies and exchange-traded funds) are valued at the last sale price quoted on the exchange where they are traded most extensively or, if there is no reported sale during the day, the closing bid quotation as reported by an independent pricing service. Securities traded on the NASDAQ Global Select Market, NASDAQ Global Market and NASDAQ Capital Market are valued at the NASDAQ Official Closing Price (“NOCP”), or if lacking an NOCP, at the most recent bid quotations on the applicable NASDAQ Market. Unlisted equity securities (except unlisted preferred equity securities) are valued at the last sale price quoted in the market where they are traded most extensively or, if there is no reported sale during the day, the closing bid quotation as reported by an independent pricing service. If there is no last sale price or closing bid quotation available, unlisted equity securities will be valued using evaluated bids furnished by an independent pricing service, if available.

 

    

In some foreign markets, an official close price and a last sale price may be available from the foreign exchange or market. In those cases, the official close price is used.

 

    

Debt securities and unlisted preferred equity securities are valued based on evaluated bids furnished to the Fund by an independent pricing service or bid prices obtained from broker-dealers.

 

    

Broker-dealer bid prices may be used to value debt and unlisted equity securities where an independent pricing service is unable to price a security or where an independent pricing service does not provide a reliable price for the security.

 

    

Fund securities and other investments for which market quotations are not readily available are valued at fair value as determined in good faith by the adviser pursuant to procedures approved by the Board of Trustees. The Fund may also value securities and other investments at fair value in other circumstances such as when extraordinary events occur after the close of a foreign market but prior to the close of the New York Stock Exchange. This may include situations relating to a single issuer (such as a declaration of bankruptcy or a delisting of the issuer’s security from the primary market on which it has traded) as well as events affecting the securities markets in general (such as market disruptions or closings and significant fluctuations in U.S. and/or foreign markets). When fair valuing its securities or other investments, the Fund may, among other things, use modeling tools or other processes that may take into account factors such as securities or other market activity and/or significant events that occur after the close of the foreign market and before the time the Fund’s net asset value (“NAV”) is calculated. Fair value pricing may require subjective determinations about the value of a security, and fair values used to determine the Fund’s NAV may differ from quoted or published prices, or from prices that are used by others, for the same securities. In addition, the use of fair value pricing may not always result in adjustments to the prices of securities held by the Fund.

 

    

As of February 28, 2022, securities held by the Fund were fair valued as follows:

 

Equity
securities1
   Percentage of
Net Assets
$31,149,048    27.0%

 

1

Certain foreign equity securities were fair valued pursuant to procedures approved by the Board of Trustees as events occurring after the close of the foreign market were believed to materially affect the value of those securities.

 

    

The books and records of the Fund are maintained in U.S. dollars. The values of securities, currencies and other assets and liabilities denominated in currencies other than U.S. dollars are translated into U.S. dollars based upon foreign exchange rates prevailing at the end of the period.

(a)

Non-income producing security.

(b)

Security invests in variable interest entities based in China.

(c)

The Fund may enter into repurchase agreements, under the terms of a Master Repurchase Agreement, under which the Fund acquires securities as collateral and agrees to resell the securities at an agreed upon time and at an agreed upon price. It is the Fund’s policy that the market value of the collateral for repurchase agreements be at least equal to 102% of the repurchase price, including interest. Certain repurchase agreements are tri-party arrangements whereby the collateral is held in a segregated account for the benefit of the Fund and on behalf of the counterparty. Repurchase agreements could involve certain risks in the event of default or insolvency of the counterparty, including possible delays or restrictions upon the Fund’s ability to dispose of the underlying securities. As of February 28, 2022, the Fund had an investment in a repurchase agreement for which the value of the related collateral exceeded the value of the repurchase agreement.

 

144A

All or a portion of these securities are exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At February 28, 2022, the value of Rule 144A holdings amounted to $5,095,517 or 4.4% of net assets.

ADR

An American Depositary Receipt is a certificate issued by a custodian bank representing the right to receive securities of the foreign issuer described. The values of ADRs may be significantly influenced by trading on exchanges not located in the United States.

Fair Value Measurements

In accordance with accounting standards related to fair value measurements and disclosures, the Fund has categorized the inputs utilized in determining the value of the Fund’s assets or liabilities. These inputs are summarized in the three broad levels listed below:

 

   

Level 1 – quoted prices in active markets for identical assets or liabilities;

 

   

Level 2 – prices determined using other significant inputs that are observable either directly, or indirectly through corroboration with observable market data (which could include quoted prices for similar assets or liabilities, interest rates, credit risk, etc.); and

 

   

Level 3 – prices determined using significant unobservable inputs when quoted prices or observable inputs are unavailable such as when there is little or no market activity for an asset or liability (unobservable inputs reflect the Fund’s own assumptions in determining the fair value of assets or liabilities and would be based on the best information available).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

The following is a summary of the inputs used to value the Fund’s investments as of February 28, 2022, at value:

Asset Valuation Inputs

 

Description

   Level 1      Level 2      Level 3      Total  

Common Stocks

           

China

   $ 9,994,735      $ 4,289,106      $ —        $ 14,283,841  

Denmark

     —          1,610,512        —          1,610,512  

France

     —          939,309        —          939,309  

Japan

     —          2,792,272        —          2,792,272  

Netherlands

     —          4,489,523        —          4,489,523  

Switzerland

     2,086,396        12,111,879        —          14,198,275  

United Kingdom

     —          4,916,447        —          4,916,447  

All Other Common Stocks*

     71,222,692               —          71,222,692  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total Common Stocks

     83,303,823        31,149,048        —          114,452,871  
  

 

 

    

 

 

    

 

 

    

 

 

 

Short-Term Investments

     —          925,803        —          925,803  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 83,303,823      $ 32,074,851      $ —        $ 115,378,674  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

*

Details of the major categories of the Fund’s investments are reflected within the Portfolio of Investments.

Industry Summary at February 28, 2022 (Unaudited)

 

Interactive Media & Services

     15.1

Internet & Direct Marketing Retail

     12.9  

Software

     12.8  

Pharmaceuticals

     9.9  

IT Services

     8.5  

Biotechnology

     6.3  

Semiconductors & Semiconductor Equipment

     4.8  

Hotels, Restaurants & Leisure

     4.7  

Aerospace & Defense

     4.3  

Machinery

     4.2  

Beverages

     3.0  

Professional Services

     2.5  

Food Products

     2.0  

Other Investments, less than 2% each

     8.1  

Short-Term Investments

     0.8  
  

 

 

 

Total Investments

     99.9  

Other assets less liabilities

     0.1  
  

 

 

 

Net Assets

     100.0
  

 

 

 

Currency Exposure Summary at February 28, 2022 (Unaudited)

 

United States Dollar

     72.9

Swiss Franc

     10.5  

Euro

     6.0  

Hong Kong Dollar

     3.7  

British Pound

     3.0  

Japanese Yen

     2.4  

Danish Krone

     1.4  
  

 

 

 

Total Investments

     99.9  

Other assets less liabilities

     0.1  
  

 

 

 

Net Assets

     100.0